Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175091-175091
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Reperfusion Injury in Patients With Acute Myocardial Infarction
Frederick G.P. Welt, Wayne Batchelor, J. Richard Spears, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 22, pp. 2196-2213
Closed Access | Times Cited: 30
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants
Shouya Feng, Matthew C Wierzbowski, Katja Hrovat-Schaale, et al.
Nature Immunology (2025)
Open Access | Times Cited: 3
Carbon quantum dots amplify beneficial effects of EGCG against neural injuries by NLRP3 inflammasome after intracerebral hemorrhage
Min Xiao, Yun Pan, Shijin Tang, et al.
International Journal of Pharmaceutics (2025), pp. 125281-125281
Closed Access | Times Cited: 2
Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 2
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Anupam Sah, Nicolas Singewald
Pharmacology & Therapeutics (2025), pp. 108825-108825
Closed Access | Times Cited: 2
Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3
Xin Liu, Yi Fang, Xinting Lv, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1457-1471
Open Access | Times Cited: 42
Hydrogen Ion Capturing Hydrogel Microspheres for Reversing Inflammaging
Dandan Zheng, Wei Chen, Tongtong Chen, et al.
Advanced Materials (2023) Vol. 36, Iss. 5
Closed Access | Times Cited: 36
Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
Pasquale Pagliaro, Cláudia Penna
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1396-1396
Open Access | Times Cited: 26
METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner
Fei Cao, Guojun Chen, Yixin Xu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Brazilin is a natural product inhibitor of the NLRP3 inflammasome
Emily McMahon, Sherihan El‐Sayed, Jack Green, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108968-108968
Open Access | Times Cited: 9
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus
Xiaoxiao Wu, Junhao Yang, Juanjie Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116261-116261
Open Access | Times Cited: 9
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Oxidative Stress and the NLRP3 Inflammasome: Focus on Female Fertility and Reproductive Health
Efthalia Moustakli, Sofoklis Stavros, Periklis Katopodis, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 36-36
Open Access | Times Cited: 1
Decursinol angelate relieves inflammatory bowel disease by inhibiting the ROS/TXNIP/NLRP3 pathway and pyroptosis
Yudi Wang, Jiamin Wang, Yonghu Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
Tim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Chemical Communications (2025)
Closed Access | Times Cited: 1
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics
Beena Briget Kuriakose, Ahmed Hussein Zwamel, Ayad Abdulrazzaq Mutar, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 1, pp. 27-40
Closed Access | Times Cited: 1
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 1
Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer’s Disease with Therapeutic Implications
Ho-Young Song, Jiyong Lee, Yeeun Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3272-3272
Open Access | Times Cited: 1
ACT001 improves OVX-induced osteoporosis by suppressing the NF-κB/NLRP3 signaling pathway
Yuan Li, Jinyu Yang, Mike Lin, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18
Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
Zhuo Yuan, Dongke Yu, Tingting Gou, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175931-175931
Open Access | Times Cited: 17
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout
Kihyoun Park, Injae Shin, Y. Kim, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Inflammasome and pyroptosis in autoimmune liver diseases
Jixuan Wang, Zhiwen Sun, Jingri Xie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads
Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 81-101
Closed Access | Times Cited: 15
The effects of NLRP3 inflammasome inhibition or knockout in experimental apical periodontitis induced in mice
Carolina Maschietto Pucinelli, Raquel Assed Bezerra da Silva, Paulo Nelson‐Filho, et al.
Clinical Oral Investigations (2024) Vol. 28, Iss. 5
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top